To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP
Gender-affirming surgery associated with sustained viral suppression
Doubling the dose of emergency contraception is a safe and effective way of overcoming efavirenz interaction
Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years
Dolutegravir superior to standard-of-care treatment in children and adolescents
Targeted screening improves TB diagnosis in people with HIV in South Africa
Social networks key to PrEP uptake in rural Kenya and Uganda
People with HIV and hepatitis B should have ongoing monitoring for liver cancer
mRNA vaccine protects monkeys against HIV-like virus
